Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
17.95
-0.15 (-0.83%)
Feb 21, 2025, 4:00 PM EST - Market closed
Orthofix Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Orthofix Medical stock have an average target of 23.33, with a low estimate of 22 and a high estimate of 24. The average target predicts an increase of 29.97% from the current stock price of 17.95.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 22, 2025.
Analyst Ratings
The average analyst rating for Orthofix Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +33.70% | Jan 22, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 → $22 | Strong Buy | Reiterates | $20 → $22 | +22.56% | Nov 8, 2024 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $18 → $24 | Hold → Strong Buy | Upgrades | $18 → $24 | +33.70% | Nov 8, 2024 |
| Roth MKM | Roth MKM | Hold → Strong Buy Upgrades $15 → $20 | Hold → Strong Buy | Upgrades | $15 → $20 | +11.42% | May 8, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 22, 2024 |
Financial Forecast
Revenue This Year
812.44M
from 746.64M
Increased by 8.81%
Revenue Next Year
863.95M
from 812.44M
Increased by 6.34%
EPS This Year
-0.12
from -4.12
EPS Next Year
-0.03
from -0.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 837.3M | 891.4M | 950.9M | |
| Avg | 812.4M | 864.0M | 918.9M | |
| Low | 779.8M | 828.1M | 877.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 12.1% | 9.7% | 10.1% | |
| Avg | 8.8% | 6.3% | 6.4% | |
| Low | 4.4% | 1.9% | 1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.12 | 0.02 | 0.45 |
| Avg | -0.12 | -0.03 | 0.32 |
| Low | -0.13 | -0.12 | 0.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.